Skip to main content
Fig. 3 | Breast Cancer Research

Fig. 3

From: Clinical significance of HER2-low expression in early breast cancer: a nationwide study from the Korean Breast Cancer Society

Fig. 3

Kaplan–Meier survival curves for BCSS stratified by pathological stage. A A significant association was observed between pathological stage and breast cancer-specific survival. Breast cancer-specific survival was significantly better in patients with HER2-low breast cancer than in those with HER2-IHC 0 breast cancer in stages I (B), II (C), and III (D)

Back to article page